Translational Development Acquisition (TDAC) Retained Earnings (2023 - 2026)

Translational Development Acquisition's Retained Earnings history runs 4 years deep, the most recent figure standing at -$6.8 million for Q1 2026.

• Quarterly Retained Earnings fell 14.77% year-over-year to -$6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.8 million (down 14.77% YoY) and the FY2025 annual result came in at -$6.5 million, down 16.87% from the prior year.
• Retained Earnings was -$6.8 million for Q1 2026 at Translational Development Acquisition, down from -$6.5 million in the prior quarter.
• Across five years, Retained Earnings topped out at $24534.0 in Q4 2023 and bottomed at -$6.8 million in Q1 2026.
• A 4-year average of -$5.3 million and a median of -$6.2 million in 2025 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2024 — Retained Earnings plunged 22917.46% — and 2026, when it slipped 14.77%.
• Translational Development Acquisition's Retained Earnings stood at $24534.0 in 2023, then plunged by 22917.46% to -$5.6 million in 2024, then dropped by 16.87% to -$6.5 million in 2025, then fell by 4.3% to -$6.8 million in 2026.
• Business Quant data shows TDAC's Retained Earnings at -$6.8 million in Q1 2026, -$6.5 million in Q4 2025, and -$6.4 million in Q3 2025.